EHR use lowers clinical trial costs, study finds | Studies link moderate drinking to greater heart risk | AAMC: U.S. suffers shortage of clinical training sites
Web Version
July 16, 2014
ASNC SmartBrief
News for nuclear cardiology and cardiovascular imaging professionals

Top Stories
EHR use lowers clinical trial costs, study finds
A British study found that EHR adoption helped researchers attain better understanding of more diverse medical patterns and identify the appropriate treatments. EHR use was also associated with greater efficacy and less cost compared with the current clinical trial process, researchers wrote in the journal Health Technology Assessment. Healthcare Informatics online (7/11)
Share: LinkedInTwitterFacebookGoogle+Email
Studies link moderate drinking to greater heart risk
A study published in the Journal of the American College of Cardiology showed that even moderate daily consumption of wine or liquor, but not beer, was associated with a higher risk of developing atrial fibrillation. The risk of developing irregular heartbeat rose 8% for each additional drink of any kind of alcohol per day, an analysis of data from six studies found. HealthDay News (7/14)
Share: LinkedInTwitterFacebookGoogle+Email
Medical Focus
AAMC: U.S. suffers shortage of clinical training sites
A report by the Association of American Medical Colleges and other health groups revealed a growing shortage of clinical training sites for medical school graduates, leading some to turn to alternatives including night shift rotations and community-based physician training. However, the American Academy of Family Physicians said medical schools are developing ways to ensure clinical training despite the apparent shortage. News (7/14)
Share: LinkedInTwitterFacebookGoogle+Email
Novartis, Google partner on contact lenses to track blood glucose levels
Novartis and Google are partnering on "smart" contact lenses that could track diabetes patients' blood glucose levels. The lenses would measure glucose in tear fluid and transmit the data to a mobile device. Novartis is also looking into remote monitoring applications for heart failure. The Globe and Mail (Toronto) (tiered subscription model)/Reuters (7/15)
Share: LinkedInTwitterFacebookGoogle+Email
Regulatory & Policy
510(k) risk-benefit review proposal issued by FDA
Draft guidance released by the FDA outlines how the agency evaluates the risks and benefits of medical devices submitted under the 510(k) clearance program. The guidance covers topics such as the type of benefits the FDA measures, as well as serious adverse events linked to medical devices. (Boston) (7/14)
Share: LinkedInTwitterFacebookGoogle+Email
Report looks at health spending growth in May 2014
A report by the Altarum Institute's Center for Sustainable Health Spending revealed total U.S. medical spending increased 4.8% in May over the same month a year ago -- a rate lower than was initially expected. The fastest growth in spending was recorded for prescription drugs at 12.2%. Healthcare Finance News/Richard Pizzi's blog (7/14)
Share: LinkedInTwitterFacebookGoogle+Email
Less than one week to register for ASNC2014 and save up to $400!
The world's top scientists and clinicians in nuclear cardiology and heart imaging will gather to present their latest research findings at ASNC2014: The 19th Annual Scientific Session of the American Society of Nuclear Cardiology, which will be held on Sept. 18-21 in Boston. Register before July 21 and save up to $400 on your registration. Register today!
Share: LinkedInTwitterFacebookGoogle+Email
ASNC to hold board exam prep course as an ancillary program of ASNC2014
ASNC is pleased to offer its Nuclear Cardiology Board Exam Preparation Course on 
Sept. 17-18 at the Seaport World Trade Center in Boston as an ancillary program of ASNC2014. This course is designed for physicians preparing for the certification or recertification exam in nuclear cardiology as well as physicians interested in a broad review in nuclear cardiology topics. Plus, if you sign up for both courses, you qualify for special registration rates. Learn more.
Share: LinkedInTwitterFacebookGoogle+Email
If I won't be myself, who will?"
-- Alfred Hitchcock,
British-American film director
Share: LinkedInTwitterFacebookGoogle+Email
Subscriber Tools
Please contact one of our specialists for advertising opportunities, editorial inquiries, job placements, or any other questions.
Editor:  Melissa Turner
Advertising:  Meryl Harold
  P: 202.407.7828

Download the SmartBrief App  iTunes / Android
iTunes  Android
Mailing Address:
SmartBrief, Inc.®, 555 11th ST NW, Suite 600, Washington, DC 20004
© 1999-2014 SmartBrief, Inc.®
Privacy policy |  Legal Information